Evidence map›Paper›PMID 26865186›Full record

ArticleEpilepsia2016

Profile of retigabine-induced neuronal apoptosis in the developing rat brain.

Lindsay Brown, Samuel Gutherz, Catherine Kulick, Colin Soper, Alexei Kondratyev, Patrick A Forcelli

Open access · bronzeAbstract read
In one paragraph

Article in Epilepsia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. KAddiction biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014.Journal of perinatology : official journal of the California Perinatal Association · 2017
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lindsay BrownDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, District of Columbia, U.S.A.
Samuel GutherzDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, District of Columbia, U.S.A.
Catherine KulickDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, District of Columbia, U.S.A.
Colin SoperDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, District of Columbia, U.S.A.
Alexei KondratyevDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, District of Columbia, U.S.A.
Patrick A ForcelliDepartment of Pharmacology & Physiology, Georgetown University School of Medicine, Washington, District of Columbia, U.S.A.
Georgetown University · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
Postdoctoral Training in Developmental Disabilities ResearchT32HD046388 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2006 to 2016
$1.5M
NCATS NIH HHS KL2 TR001432NCATS NIH HHS KL2TR001432NCI NIH HHS P30 CA051008NCI NIH HHS P30CA051008NICHD NIH HHS HD046388NICHD NIH HHS T32 HD046388
6 · The paper itself

Abstract

objectiveAcute neonatal exposure to some, but not all, anticonvulsant drugs induces a profound increase in neuronal apoptosis in rats. Phenobarbital and phenytoin induce apoptosis at a therapeutically relevant dose range, lamotrigine and carbamazepine do so only at supratherapeutic doses or in polytherapy, and valproate does so even at subtherapeutic doses. Levetiracetam is devoid of pro-apoptotic effects. Retigabine, a new-generation drug, acts uniquely by enhancing the M-type potassium current. Because its safety profile in developing animals is unstudied, we sought to determine if retigabine would induce apoptosis.

methodsPostnatal day (P) 7 rat pups were treated with retigabine (5-30 mg/kg), vehicle (saline), or comparator drugs (phenobarbital, lamotrigine, levetiracetam, or carbamazepine). Cell death was assessed using amino-cupric-silver staining. A separate group of animals was treated repeatedly (three times over 24 h) with retigabine (15 mg/kg) or vehicle. To establish a pharmacokinetic profile for retigabine, we measured plasma and brain levels after drug treatment.

resultsConsistent with prior studies from our group and others, we found phenobarbital-induced cell death throughout thalamus, nucleus accumbens, and several neocortical areas. By contrast, levetiracetam, lamotrigine, and carbamazepine were found to have no appreciable apoptotic effect on the aforementioned structures. Acute (single) exposure to retigabine, even at doses of 30 mg/kg, was also without effect on apoptosis. However, repeated (three times) exposure to retigabine triggered apoptosis in a subset of brain areas. The half-life of retigabine in plasma was 2.5 h, with appreciable concentrations reached in the brain within 1 h of administration. SIGNIFICANCE: These data demonstrate that retigabine, like many other anticonvulsant drugs, is capable of triggering neuronal apoptosis in the developing rat brain. Unlike other drugs, repeated dosing of retigabine was necessary to induce this effect. This may be due to its shorter half-life as compared to other drugs, such as phenobarbital.

Indexed as

AnimalsAnimals, NewbornAnticonvulsantsApoptosisBrainCarbamatesDose-Response Relationship, DrugMaleNeuronsPhenylenediaminesRatsRats, Sprague-DawleyAnticonvulsantsCarbamatesezogabinePhenylenediaminesCell deathGestationalNeonatalTeratogen

Identifiers

PMID26865186
PMCPMC5214840
OpenAlexW2268771989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.